IMG Culture
Innovative Medicines Group (IMG) is a privately held company created with the objective of fulfilling the very specific and special medical needs of a small population of adults and children seeking life-preserving therapeutics for rare diseases. Following the leadership of our partners around the world and under the management of a highly experienced team, IMG pursues the objective of becoming the leading biopharmaceutical research company in Latin America. The company is currently seeking strategic alliances and is dedicated to acquiring or developing, registering and marketing specialty medicines with high medical value.
Vision
Our vision is to become the most efficient and dynamic regional pharmaceutical company providing orphan drugs, services and niche specialty pharmaceuticals to fulfill the medical needs of a small population of adults and children seeking life-preserving therapeutics for rare diseases.
Services
We specialize in the development, marketing and distribution of products used to treat rare diseases where current therapies in Latin America are unavailable, incomplete or inadequate. We also offer services to many pharmaceutical companies, CROs, and consultacy firms seeking to maximize their results in Latin America.
Ethics & Compliance
IMG applies compliance principles and policies with the objective of implementing practices that comply with local laws, respecting its ethical code of conduct and all its integrity policies. All our compliance concepts are in alignment with IMG values, respecting and serving patients with the integrity and transparency all stakeholders need to achieve the same objective of improving treatment outcome and quality of life for each patient. They also promote ethical behavior and the application of our values to all processes and activities that IMG develops based on detection systems and risk management procedures.
Partnering
Unleash your product full potential with our regional presence and comprehensive services in Latin America!
Pharma: Seeking dynamic partnerships with companies at the forefront of developing cutting-edge therapeutic assets and platforms. Together, we aim to deliver substantial benefits to patients, healthcare providers, and payers, permanently innovating our core therapeutic areas.
Research: Internationally, IMG collaborates with esteemed researchers hailing from top-tier universities, academic medical centers, research institutes, and distinguished centers of excellence.
For further information, please contact us at info@imedicinesgroup.com or info@innovativemedicines.com
